Status:
COMPLETED
Diagnostic Performance of Exome Sequencing in Autism Spectrum Disorders
Lead Sponsor:
University Hospital, Rouen
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
Brief Summary
Evaluation of the diagnostic performance of exome sequencing in a prospective series of patients with autism spectrum disorders (ASD).
Eligibility Criteria
Inclusion
- Patient with ASD who has been previously diagnosed by an expert center according to the DSM5 criteria using standardized instruments (ADOS, ADI-R), referred to genetic consultation by the psychiatrist who performed the clinical diagnosis, according to the recommendations of the HAS, and requesting a genetic analysis for medical purposes in this context.
- Patient over 3 years old
- Patient affiliated to a social security scheme
- For minor patients: Holders of the exercise of parental authority who have read and understood the newsletter and signed the consent form
- For a major patient: Major patient who has read and understood the newsletter and signed the consent form
- Supervised minor / minor patient: Legal representative who has read and understood the newsletter and signed the consent form
- Major patient under guardianship: Major patient assisted by his curator or by the judge having read and understood the newsletter and signed the consent form
- DNA of the patient and parents available
Exclusion
- Patient who has already benefited from exome sequencing
- Person deprived of liberty by an administrative or judicial decision
- Pregnant or lactating woman
Key Trial Info
Start Date :
June 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 19 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04043351
Start Date
June 12 2019
End Date
October 19 2021
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DRCI
Rouen, France, 76000